Minimizing the environmental footprint of bioprocesses

BioProcess International

Volumn 8, Issue 8, 2010, Pages 62-71

  Junker, Beth ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Disposables; Environmental impact; Single use; Sustainability

Indexed keywords

GLYCEROL; PIGMENT; SOLVENT; STAINLESS STEEL; SUCCINIC ACID; TYROSINE; VITAMIN;

BIOCATALYST; BIOPROCESS; BIOTECHNOLOGY; CULTURE MEDIUM; DISPOSABLE EQUIPMENT; DRUG INDUSTRY; ENVIRONMENTAL IMPACT ASSESSMENT; ENVIRONMENTAL SUSTAINABILITY; ESCHERICHIA COLI; FERMENTATION; GOVERNMENT REGULATION; NONHUMAN; PICHIA PASTORIS; REVIEW; SACCHAROMYCES CEREVISIAE; SOLID WASTE MANAGEMENT; UNITED STATES;

EID: 77957028965     PISSN: 15426319     EISSN: None     Source Type: Trade Journal    
DOI: None     Document Type: Review

References (36)

1. Duran N, et al. Ecological-Friendly Pigments from Fungi. Crit. Rev. Food Sci. Nutrition 42(1) 2002: 53-66.
2. Thayer AM. Supplanting Oil. Chem. Eng. News 87(15) 2009: 22-26.
3. Lütke-Eversloh T, Santos CNS, Stephanopoulos G. Perspectives of Biotechnological Production of L-tyrosine and Its Applications. Appl. Microbiol. Biotechnol. 77, 2007: 751-762.
4. Jenck JF, Agterberg F, Droescher MJ. Projects and Processes for a Sustainable Chemical Industry: A Review of Achievements and Prospects. Green Chem. 6, 2004: 544-556. (Pubitemid 39636064)
5. Linich D, Park C. It's Not Easy Being Green - Unless You're Lean. iSixSigma Magazine, Jan/Feb 2009: 45-50.
6. Chatterjee B. Lean Sustainability: Extending the Operational Excellence Paradigm. Controlled Environ. 12, 2009: 6, 19-21.
7. Sciortino M, Watson S. The Importance of Energy Efficiency in Lean Manufacturing: Declaring Energy the Ninth Waste. ACEEE Summary Study on Energy Efficiency in Industry, American Council for an Energy Efficient Economy. 2009: 3-113 to 3-122.
8. Calia RC, Guerrin FM, de Castro M. The Impact of Six Sigma in the Performance of a Pollution Prevention Program. J. Cleaner Production 17, 2009: 1303-1310.
9. Jacobs T. Taking the Lead in CGMPs: Is a Sustainable GMP Manufacturing Facility Achievable? Contract Pharma April 2007: 82-87.
10. Facility of the Year Award Winner, Sustainability, Centocor Biologics, Ireland. Pharma. Pro. March 2008: 24.
11. Fitzgerald D, Bradley, K. Speed and Efficiency in Designing and Building a Monoclonal Antibody Pilot Plant. BioPharm Int. 22(3) 2009: 24-31.
12. Harrold D. Going Green with MES. Control 22(7) 2009: 33-35.
13. El-Halwagi MM, et al. Apply Process Integration to Environmental Impact Assessment. CEP 105(2) 2009: 36-42.
14. Sheldon RA. Consider the Environmental Quotient. ChemTech 24 (3) 1994: 38-47.
15. Ho SV, et al. Environmental Considerations in Biologics Manufacturing. Green Chem 12, 2010: 755-766.
16. Kidwell M. Lean Manufacturing: The Environment and the Bottom Line. GreenBiz.com 12 July 2000: http://greenbiz.com/print/530.
17. Rawlings B, Pora H. A Prescriptive Approach to Management of Solid Waste from Single-Use Systems. BioProcess Int. 7(3) 2009: 40-47.
18. Newman D, Isner V. Environmental Considerations for Biomanufacturing Processes. French Industri Pharma 32, 2004: page numbers not available.
19. Mauter M. Environmental Life-Cycle Assessment of Disposable Bioreactors. BioProcess Intl. 7(4) 2009: S18-S41.
20. Sinclair A, et al. The Environmental Impact of Disposable Technologies. BioPharm International Supplement Guide to Disposables Nov 2008: 4-15.
21. Papavasileiou V, Siletti C, Demetri P. The Role of Single-Use Systems (Disposables) in the Development and Manufacturing of Biopharmaceuticals. Pharma. Chem. 8(1-2) 2009: 14-20.
22. Patterson BJ. A Closer Look at Automated In-Line Dilution. BioPharm Int. 22(10) 2009: 52-65.
23. Trexler-Schmidt M, et al. Purification Strategies to Process 5 g/L Titers of Monoclonal Antibodies. BioPharm International Supplement, Advances in Separation and Purification: Purifying High Titers, March 2009: 8-15.
24. Anicetti V. Biopharmaceutical Processes: A Glance into the 21st Century. BioProcess Int. 7(1) 2009: S4-S11.
25. Zhou J, et al. Implementation of Advanced Technologies in Commercial Monoclonal Antibody Production. Biotechnol. J. 3(9-10) 2008: 1185-1200.
26. Rao G, Moreira A, Brorson K. Disposable Bioprocessing: The Future Has Arrived. Biotechnol. Bioeng. 102(2) 2009: 348-356.
27. Panda AK. Bioprocessing of Therapeutic Proteins from the Inclusion Bodies of Escherichia coli. Adv. Biochem. Engin. Biotechnol. 85, 2003: 43-93.
28. Wegner EH. Biochemical Conversions by Yeast Fermentation at High Cell Densities. US Patent #4,617,274, 1986.
29. Potgieter T, et al. Production of Monoclonal Antibodies by Glycoengineered Pichia pastoris. J. Biotechnol. 139, 2009: 318-325.
30. Hang H, et al. A Simple Fermentation Strategy for High-Level Production of Recombinant Phytase by Pichia pastoris Using Glucose as the Growth Substrate. Enzyme and Microbial Technol. 44, 2009: 185-188.
31. Markl H, Cultivation of Escherichia coli to High Cell Densities in a Dialysis Reactor. Appl. Microbiol. Biotechnol. 39, 1993: 48-52
32. Fuchs C, et al. Scale Up of Dialysis Fermentation for High Cell Density Cultivation of Escherichia coli. J. Biotechnol. 93, 2002: 243-251. (Pubitemid 34084858)
33. Wang DIC, et al. Fermentation and Enzyme Technology. John Wiley and Sons: New York, NY, 1979; 94-95.
34. Doran PM. Bioprocess Engineering Principles. Academic Press: New York, NY; 75.
35. Zabriskie DW, et al. Traders' Guide to Fermentation Media Formulation, Traders' Protein: Memphis, TN, 1999.
36. Gurramkonda C, et al. Simple High Cell Density Fed-Batch Technique for High-Level Recombinant Protein Production with Pichia pastoris: Application to Intracellular Production of Hepatitis B Surface Antigen. Microbial Cell Factories 8(1) 2009: 13-20.